This report contains market size and forecasts of Translational Regenerative Medicine in global, including the following market information:
- Global Translational Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Translational Regenerative Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Translational Regenerative Medicine companies in 2021 (%)
The global Translational Regenerative Medicine market was valued at 12590 million in 2021 and is projected to reach US$ 29460 million by 2028, at a CAGR of 12.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Translational Regenerative Medicine include Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics and Pharmicell, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Translational Regenerative Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Translational Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)
- Stem Cell Therapy
- Tissue Engineering
- Gene Therapy
Global Translational Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)
- Tissue Engineering Therapy
- Wound Healing
- Cartilage Repair
- Other
Global Translational Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Translational Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Translational Regenerative Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Translational Regenerative Medicine revenues share in global market, 2021 (%)
- Key companies Translational Regenerative Medicine sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Translational Regenerative Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Athersys
- Avita Medical
- AxoGen
- MEDIPOST
- NuVasive
- Astellas Pharma
- Organogenesis Holdings
- Osiris Therapeutics
- Pharmicell
- Regenerys
- Takeda Pharmaceutical
- uniQure
- Vericel
